Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 28, 2016 08:01 ET | Source: Traws Pharma, Inc.

Onconova Therapeutics, Inc. Reports Recent Business Highlights and Year-end 2015 Financial Results

NEWTOWN, Pa., March 28, 2016 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
March 21, 2016 07:01 ET | Source: Traws Pharma, Inc.

Onconova Enrolls First Patient in Europe for Phase 3 INSPIRE Trial of Rigosertib in Higher-Risk Myelodysplastic Syndromes

NEWTOWN, Pa., March 21, 2016 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to...
March 09, 2016 07:01 ET | Source: Traws Pharma, Inc.

Onconova Announces Publication of Rigosertib Phase 3 ONTIME Data in Lancet Oncology

-- Online-First Publication Currently Available -- -- First Randomized Trial With Survival Endpoint in Second-Line Myelodysplastic Syndromes (MDS) -- -- New Phase 3 “INSPIRE” Study of IV...
March 03, 2016 19:10 ET | Source: Traws Pharma, Inc.

Onconova Therapeutics, Inc. Receives Notice of Termination for Convenience from Baxalta

NEWTOWN, Pa., March 03, 2016 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
February 04, 2016 17:01 ET | Source: Traws Pharma, Inc.

Onconova Therapeutics, Inc. Announces Listing Transfer to NASDAQ Capital Market

NEWTOWN, Pa., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to...
February 01, 2016 08:01 ET | Source: Traws Pharma, Inc.

Onconova Therapeutics, Inc. to Present Corporate Update at the 18th Annual BIO CEO & Investor Conference

NEWTOWN, Pa., Feb. 01, 2016 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
January 06, 2016 08:45 ET | Source: Traws Pharma, Inc.

Onconova Therapeutics Announces Registered Direct Offering

NEWTOWN, PA., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
December 14, 2015 09:15 ET | Source: Traws Pharma, Inc.

Onconova to Host Myelodysplastic Syndromes (MDS) Key Opinion Leader Meeting on Wednesday, December 16, in New York City

NEWTOWN, Pa., Dec. 14, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
December 07, 2015 19:01 ET | Source: Traws Pharma, Inc.

Onconova Presents Positive Data From Phase 2 Combination Trial of Oral Rigosertib and Azacitidine in Higher-Risk Myelodysplastic Syndromes at 2015 ASH Annual Meeting

--Combination Achieved 77% Overall Response Rate in all MDS Patients-- --Overall Response Rate of 84% in treatment-naïve MDS Patients-- --Response Rate of 64% in MDS Patients who had Previously...
December 07, 2015 08:01 ET | Source: Traws Pharma, Inc.

Onconova Enrolls First Patient in Phase 3 INSPIRE Trial of Rigosertib

NEWTOWN, Pa., Dec. 07, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...